Clinical Research Facility
Loma Linda, California
We've found
9 trials
at this facility
Urothelial Carcinoma Associated 1 RNA, Human Clinical Trial
Updated: 12/31/1969
Study of Pembrolizumab With or Without Platinum-based Combination Chemotherapy Versus Chemotherapy Alone in Urothelial Carcinoma (MK-3475-361/KEYNOTE-361)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing-Remitting Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
Phase 3 Efficacy and Safety Study of BG00012 in Pediatric Subjects With Relapsing-remitting Multiple Sclerosis (RRMS)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
Updated: 12/31/1969
OPsumit USers Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Observational Study of Obstructive Lung Disease (NOVELTY)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
Registrational Study With Omecamtiv Mecarbil/AMG 423 to Treat Chronic Heart Failure With Reduced Ejection Fraction
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
Dimethyl Fumarate (DMF) Observational Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Systemic Lupus Erythematosus Clinical Trial
Updated: 12/31/1969
Systemic Lupus Erythematosus (SLE) Prospective Observational Cohort Study (SPOCS)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Epilepsy, Focal Seizures, Partial Seizures Clinical Trial
Updated: 12/31/1969
Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure With Preserved Ejection Fraction Clinical Trial
Updated: 12/31/1969
Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials